Breaking News

Quanticate Launches QVigilance

For the support of small and mid-size companies transitioning from clinical trials to post-marketing and establishing compliant PV systems

Quanticate has launched QVigilance to provide dedicated pharmacovigilance (PV) and risk management services. QVigilance will be focused on supporting small and mid-size companies transitioning from clinical trials to post-marketing and establishing compliant PV systems. Quanticate offers the full range of global PV services to clinical trial sponsors and market authorization holders (MAHs) in the pharmaceutical, biopharma and medical device sectors including: Case processing and repor...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters